Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Genomic Profiling”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)Looking for participantsNCT04341181
What this trial is testing

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

Who this might be right for
CancerTumorsNeoplasms+1 more
Ulrik Lassen 300
Not applicableActive Not RecruitingNCT02713334
What this trial is testing

Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

Who this might be right for
Tumor Genomic Profiling
Memorial Sloan Kettering Cancer Center 495
Not applicableUnknownNCT03963700
What this trial is testing

Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)

Who this might be right for
CancerParaneoplastic SyndromesNeurologic Disorder+2 more
Hospices Civils de Lyon 980
Not applicableUnknownNCT02749838
What this trial is testing

Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

Who this might be right for
Cancer
Pharmatech 183
Not applicableEnded earlyNCT00473850
What this trial is testing

Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC

Who this might be right for
Exostoses, Multiple Hereditary
University of British Columbia 2,000
Not applicableUnknownNCT01907438
What this trial is testing

Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells

Who this might be right for
BRCA1 Gene MutationBRCA2 Gene Mutation
Hadassah Medical Organization 30
Not applicableStudy completedNCT02625935
What this trial is testing

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Who this might be right for
Breast Cancer
NanoString Technologies, Inc. 206
Not applicableActive Not RecruitingNCT07796594
What this trial is testing

Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer

Who this might be right for
MelanomaPancreas Cancer
Amsterdam UMC, location VUmc 180
Not applicableStudy completedNCT01454297
What this trial is testing

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

Who this might be right for
Multiple Myeloma
Multiple Myeloma Research Foundation 1,154
Not applicableLooking for participantsNCT05236114
What this trial is testing

GEMINI-NSCLC: NSCLC Biomarker Study

Who this might be right for
Non-Small Cell Lung Cancer
Tempus AI 1,200
Not applicableLooking for participantsNCT04504604
What this trial is testing

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

Who this might be right for
Rare CancersCholangiocarcinomaCancer of Unknown Primary Site
TargetCancer Foundation 400
Not applicableLooking for participantsNCT06354738
What this trial is testing

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment

Who this might be right for
Endometrial Cancer
University Hospital, Gasthuisberg 1,000
Not applicableStudy completedNCT03766672
What this trial is testing

Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique

Who this might be right for
Endometrial Neoplasms
University Hospital Center of Martinique 30
Not applicableLooking for participantsNCT02534649
What this trial is testing

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

Who this might be right for
Solid TumorHematological Malignancy
Institut Bergonié 10,000
Not applicableStudy completedNCT02679950
What this trial is testing

Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse

Who this might be right for
Neoplasms, Germ Cell and Embryonal
Nasser Hanna 6
Not applicableStudy completedNCT03772197
What this trial is testing

Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)

Who this might be right for
Breast CancerRecurrence
Amwise Diagnostics Pte. Ltd. 138
Not applicableStudy completedNCT04362852
What this trial is testing

Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis

Who this might be right for
Eczema/Atopic DermatitisCancer
Boston Children's Hospital 100
Not applicableStudy completedNCT05916378
What this trial is testing

Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Who this might be right for
Breast Cancer
Stanford University 514
Not applicableEnded earlyNCT01598285
What this trial is testing

A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer

Who this might be right for
Breast Cancer Invasive Nos
Spanish Breast Cancer Research Group 26
Not applicableStudy completedNCT01219829
What this trial is testing

Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Columbia University 5
Next Page